.jpg&contenttype=jpeg)
Categories
Diabetics and drug-eluting stents
Boston Scientific Corporation has announced results from a pooled analysis of patients from its TAXUS IV and TAXUS V randomised clinical trials to compare the safety and efficacy Read more …
Taxus produces similar outcomes in men & women
Results of a gender-specific study to assess the efficacy of the Taxus paclitaxel-eluting coronary stent in women undergoing coronary revascularisation were released at the Read more …
E-SIRIUS Trial: Safety and efficacy of drug-eluting stents
Cordis Corporations’ CYPHER stent is a Sirolimus-eluting coronary stent used for treatment of patients with coronary artery disease. The five-year results of the E-Sirius Trial Read more …
Platinum chromium alloy enhances design
Boston Scientific Corporation has commenced enrolment of a targeted 1,500 patients for the Taxus Perseus clinical trials, planned to take place in 100 international centres. Read more …
For and against - Absorbable metal stents
Coronary stents provide wall wrapping of dissection, prevent elastic recoil, and reduce restenosis after percutaneous transluminal coronary angioplasty. In addition, drug eluting Read more …
Carotid stenting suffers a setback
The debate between carotid artery stenting (CAS) and carotid endarterectomy (CEA) - the surgical approach - for treating a narrowing of the carotid artery in the neck to prevent Read more …
Coronary Heart Disease
With ever-improving stents, cardiologists can deal with ever more complex cases. Will bypass surgery soon be a thing of the past?
Read more …
Coronary artery disease in diabetes mellitus
Recent advances in percutaneous coronary intervention (PCI) may offer a new approach to treating this complex group of patients.
Read more …
Carotid stenting: ‘a feeding frenzy’
Vascular experts urge caution over stent lacement to prevent stroke.
Read more …
